Advanced search
Publication Cover
Nanomedicine Volume 7, 2012 - Issue 3
Submit an article Journal homepage
440
Views
0
CrossRef citations to date
0
Altmetric
Review

Tapping The Potential of Quantum Dots for Personalized Oncology: Current Status and Future Perspectives

Chuang Chen1 Department of Oncology, Zhongnan Hospital of Wuhan University & Hubei Key Laboratory of Tumor Biological Behaviors & Hubei Cancer Clinical Study Center, No 169 Donghu Road, Wuchang District, Wuhan430071, PR China.;2 Department of Breast & Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei430060, PR ChinaView further author information
,
Jun Peng3 Key Laboratory of Analytical Chemistry for Biology & Medicine (Ministry of Education), College of Chemistry & Molecular Sciences, Research Center for Nanobiology & Nanomedicine (MOE 985 Innovative Platform), & State Key Laboratory of Virology, Wuhan University, Wuhan, 430072, PR China;4 Wuhan Jiayuan Quantum Dots Co. Ltd & Wuhan Tumor Nanometer Diagnosis Engineering Research Center, Wuhan430074, PR ChinaView further author information
,
Sheng-Rong Sun2 Department of Breast & Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei430060, PR ChinaView further author information
,
Chun-Wei Peng1 Department of Oncology, Zhongnan Hospital of Wuhan University & Hubei Key Laboratory of Tumor Biological Behaviors & Hubei Cancer Clinical Study Center, No 169 Donghu Road, Wuchang District, Wuhan430071, PR China.View further author information
,
Yan Li1 Department of Oncology, Zhongnan Hospital of Wuhan University & Hubei Key Laboratory of Tumor Biological Behaviors & Hubei Cancer Clinical Study Center, No 169 Donghu Road, Wuchang District, Wuhan430071, PR China. [email protected]Correspondence[email protected]
View further author information
&
Dai-Wen Pang3 Key Laboratory of Analytical Chemistry for Biology & Medicine (Ministry of Education), College of Chemistry & Molecular Sciences, Research Center for Nanobiology & Nanomedicine (MOE 985 Innovative Platform), & State Key Laboratory of Virology, Wuhan University, Wuhan, 430072, PR ChinaView further author information
Pages 411-428 | Published online: 02 Mar 2012

References

  • Jemal A , BrayF, CenterMM, FerlayJ, WardE, FormanD. Global cancer statistics. CA Cancer J. Clin.61, 69–90 (2011).
  • Smith RA , CokkinidesV, BrooksD, SaslowD, ShahM, BrawleyOW. Cancer screening in the United States, 2011: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J. Clin.61, 8–30 (2011).
  • Stewart DJ , KurzrockR. Cancer: the road to Amiens. J. Clin. Oncol.27, 328–333 (2009).
  • Cance WG . Society of surgical oncology presidential address: the war on cancer – shifting from disappointment to new hope. Ann. Surg. Oncol.17, 1971–1978 (2010).
  • Marshall E . Cancer research and the $90 billion metaphor. Science331, 1540–1541 (2011).
  • Jemal A , SiegelR, XuJ, WardE. Cancer statistics, 2010. CA Cancer J. Clin.60, 277–300 (2010).
  • Sankaranarayanan R , SwaminathanR, BrennerHet al. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol. 11, 165–173 (2010).
  • Marusyk A , PolyakK. Tumor heterogeneity: causes and consequences. Biochim. Biophys. Acta1805(1), 105–117 (2010).
  • Hanash SM , BaikCS, KallioniemiO. Emerging molecular biomarkers – blood-based strategies to detect and monitor cancer. Nat. Rev. Clin. Oncol.8, 142–150 (2011).
  • Weissleder R . Molecular imaging in cancer. Science312, 1168–1171 (2006).
  • Weissleder R , PittetMJ. Imaging in the era of molecular oncology. Nature452, 580–589 (2008).
  • van der Meel R , GallagherWM, OliveiraS, O‘ConnorAE, SchiffelersRM, ByrneAT. Recent advances in molecular imaging biomarkers in cancer: application of bench to bedside technologies. Drug Discov. Today15, 102–114 (2010).
  • Glunde K , PathakAP, BhujwallaZM. Molecular-functional imaging of cancer: to image and imagine. Trends Mol. Med.13, 287–297 (2007).
  • Harris TJ , McCormickF. The molecular pathology of cancer. Nat. Rev. Clin. Oncol.7, 251–265 (2010).
  • Ludwig JA , WeinsteinJN. Biomarkers in cancer staging, prognosis and treatment selection. Nat. Rev. Cancer5, 845–856 (2005).
  • Duffy MJ , CrownJ. A personalized approach to cancer treatment: how biomarkers can help. Clin. Chem.54, 1770–1779 (2008).
  • Wistuba II , GelovaniJG, JacobyJJ, DavisSE, HerbstRS. Methodological and practical challenges for personalized cancer therapies. Nat. Rev. Clin. Oncol.8, 135–141 (2011).
  • Phan JH , MoffittRA, StokesTHet al. Convergence of biomarkers, bioinformatics and nanotechnology for individualized cancer treatment. Trends Biotechnol. 27, 350–358 (2009).
  • Wang X , YangL, ChenZG, ShinDM. Application of nanotechnology in cancer therapy and imaging. CA Cancer J. Clin.58, 97–110 (2008).
  • Peer D , KarpJM, HongS, FarokhzadOC, MargalitR, LangerR. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol.2, 751–760 (2007).
  • Torigian DA , HuangSS, HouseniM, AlaviA. Functional imaging of cancer with emphasis on molecular techniques. CA Cancer J. Clin.57, 206–224 (2007).
  • Frangioni JV . New technologies for human cancer imaging. J. Clin. Oncol.26, 4012–4021 (2008).
  • Kim J , PiaoY, HyeonT. Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. Chem. Soc. Rev.38, 372–390 (2009).
  • Hong H , ZhangY, SunJ, CaiW. Molecular imaging and therapy of cancer with radiolabeled nanoparticles. Nano Today4, 399–413 (2009).
  • Cho EC , GlausC, ChenJ, WelchMJ, XiaY. Inorganic nanoparticle-based contrast agents for molecular imaging. Trends Mol. Med.16, 561–573 (2010).
  • Farrell D , AlperJ, PtakK, PanaroNJ, GrodzinskiP, BarkerAD. Recent advances from the National Cancer Institute Alliance for nanotechnology in cancer. ACS Nano4, 589–594 (2010).
  • Singhal S , NieS, WangMD. Nanotechnology applications in surgical oncology. Annu. Rev. Med.61, 359–373 (2010).
  • Nie S , XingY, KimGJ, SimonsJW. Nanotechnology applications in cancer. Annu. Rev. Biomed. Eng.9, 257–288 (2007).
  • Ferrari M . Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer5, 161–171 (2005).
  • Michalet X , PinaudFF, BentolilaLAet al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307, 538–544 (2005).
  • Chen C , ChenLD, ZhangZL, LiY. Advances in the application of quantum dots in tumor markers investigation. Chin. Germ. J. Clin. Oncol.7, 1079–1084 (2008).
  • Peng CW , LiY. Application of quantum dots-based biotechnology in cancer diagnosis: current status and future perspectives. J. Nanomater.676839, 1–11 (2010).
  • Zrazhevskiy P , GaoX. Multifunctional quantum dots for personalized medicine. Nano Today4, 414–428 (2009).
  • Zrazhevskiy P , SenaM, GaoX. Designing multifunctional quantum dots for bioimaging, detection, and drug delivery. Chem. Soc. Rev.39, 4326–4354 (2010).
  • Smith AM , DaveS, NieS, TrueL, GaoX. Multicolor quantum dots for molecular diagnostics of cancer. Expert Rev. Mol. Diagn.6(2), 231–244 (2006).
  • Resch-Genger U , Grabolle, Cavaliere-Jaricot S, Nitschke R, Nann T. Quantum dots versus organic dyes as fluorescent labels. Nat. Methods5, 763–775 (2008).
  • Tholouli E , SweeneyE, BarrowE, ClayV, HoylandJ, ByersR. Quantum dots light up pathology. J. Pathol.216, 275–285 (2008).
  • Smith AM , DuanH, MohsAM, NieS. Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv. Drug Deliv. Rev.60, 1226–1240 (2008).
  • Bentolila LA , EbensteinY, WeissS. Quantum dots for in vivo small-animal imaging. J. Nucl. Med.50, 493–496 (2009).
  • Kosaka N , McCannTE, MitsunagaM, ChoykePL, KobayashiH. Real-time optical imaging using quantum dot and related nanocrystals. Nanomedicine5, 765–776 (2010).
  • Hilderbrand SA , WeisslederR. Near-infrared fluorescence: application to in vivo molecular imaging. Curr. Opin. Chem. Biol.14, 71–79 (2010).
  • He X , GaoJ, GambhirSS, ChengZ. Near-infrared fluorescent nanoprobes for cancer molecular imaging: status and challenges. Trends Mol. Med.16, 574–583 (2010).
  • Wang Y , ChenL. Quantum dots, lighting up the research and development of nanomedicine. Nanomedicine7, 385–402 (2011).
  • Byers RJ , HitchmanER. Quantum dots brighten biological imaging. Prog. Histochem. Cytochem.45, 201–237 (2011).
  • Wagner MK , LiF, LiJ, LiXF, LeXC. Use of quantum dots in the development of assays for cancer biomarkers. Anal. Bioanal. Chem.397, 3213–3224 (2010).
  • Rosenthal SJ , ChangJC, KovtunO, McBrideJR, TomlinsonID. Biocompatible quantum dots for biological applications. Chem. Biol.18, 10–24 (2011).
  • Medintz IL , MattoussiH, ClappAR. Potential clinical applications of quantum dots. Int. J. Nanomedicine3, 151–167 (2008).
  • Zhang H , YeeD, WangC. Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives. Nanomedicine3, 83–91 (2008).
  • True LD , GaoX. Quantum dots for molecular pathology: their time has arrived. J. Mol. Diagn.9, 7–11 (2007).
  • Jamieson T , BakhshiR, PetrovaD, PocockR, ImaniM, SeifalianAM. Biological applications of quantum dots. Biomaterials28, 4717–4732 (2007).
  • Gao X , YangL, PetrosJA, MarshallFF, SimonsJW, NieS. In vivo molecular and cellular imaging with quantum dots. Curr. Opin. Biotechnol.16, 63–72 (2005).
  • Algar WR , KrullUJ. Quantum dots as donors in fluorescence resonance energy transfer for the bioanalysis of nucleic acids, proteins, and other biological molecules. Anal. Bioanal. Chem.391, 1609–1618 (2008).
  • Xia Z , RaoJ. Biosensing and imaging based on bioluminescence resonance energy transfer. Curr. Opin. Biotechnol.20, 37–44 (2009).
  • Bruchez M Jr, Moronne M, Gin P, Weiss S, Alivisatos AP. Semiconductor nanocrystals as fluorescent biological labels. Science281, 2013–2016 (1998).
  • Chan WC , NieSM. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science281, 2016–2018 (1998).
  • Mankoff DA . A definition of molecular imaging. J. Nucl. Med.48, 18N–21N (2007).
  • Yang L , MaoH, WangYAet al. Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging. Small 5, 235–243 (2009).
  • Yong KT , DingH, RoyIet al. Imaging pancreatic cancer using bioconjugated InP quantum dots. ACS Nano 3, 502–510 (2009).
  • Diagaradjane P , Orenstein-CardonaJM, Colon-CasasnovasNEet al. Imaging epidermal growth factor receptor expression in vivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe. Clin. Cancer Res. 14, 731–741 (2008).
  • Biju V , ItohT, IshikawaM. Delivering quantum dots to cells: bioconjugated quantum dots for targeted and nonspecific extracellular and intracellular imaging. Chem. Soc. Rev.39, 3031–3056 (2010).
  • Wang C , GaoX, SuX. In vitro and in vivo imaging with quantum dots. Anal. Bioanal. Chem.397, 1397–1415 (2010).
  • Akerman ME , ChanWC, LaakkonenP, BhatiaSN, RuoslahtiE. Nanocrystal targeting in vivo. Proc. Natl Acad. Sci. USA99, 12617–12621 (2002).
  • Gao XH , CuiYY, LevensonRM, ChungLW, NieS. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol.22, 969–976 (2004).
  • Gao XH , ChungLW, NieSM. Quantum dots for in vivo molecular and cellular imaging. Methods Mol. Biol.374, 135–146 (2007).
  • Cai W , ShinDW, ChenKet al. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett. 6, 669–676 (2006).
  • Cai W , ChenK, LiZB, GambhirSS, ChenX. Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature. J. Nucl. Med.48, 1862–1870 (2007).
  • Yu X , ChenL, LiKet al. Immunofluorescence detection with quantum dot bioconjugates for hepatoma in vivo. J. Biomed. Opt. 12, 014008 (2007).
  • Yu X , ChenL, DengYet al. Fluorescence analysis with quantum dot probes for hepatoma under one- and two-photon excitation. J. Fluoresc. 17, 243–247 (2007).
  • Chen LD , LiuJ, YuXFet al.: In vivo targeted imaging of hepatocellular carcinoma in nude mice using quantum dot probes. Chin. J. Pathol.36, 394–399 (2007).
  • Chen LD , LiuJ, YuXFet al. The biocompatibility of quantum dot probes used for the targeted imaging of hepatocellular carcinoma metastasis. Biomaterials 29, 4170–4176 (2008).
  • Kim S , LimYT, SolteszEGet al. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat. Biotechnol. 22, 93–97 (2004).
  • Hama Y , KoyamaY, UranoY, ChoykePL, KobayashiH. Simultaneous two-color spectral fluorescence lymphangiography with near infrared quantum dots to map two lymphatic flows from the breast and the upper extremity. Breast Cancer Res. Treat.103, 23–28 (2007).
  • Kobayashi H , HamaY, KoyamaYet al. Simultaneous multicolor imaging of five different lymphatic basins using quantum dots. Nano Lett. 7, 1711–1716 (2007).
  • Kosaka N , OgawaM, SatoN, ChoykePL, KobayashiH. In vivo real-time, multicolor, quantum dot lymphatic imaging. J. Invest. Dermatol.129, 2818–2822 (2009).
  • Pons T , PicE, LequeuxNet al. Cadmium-free CuInS2/ZnS quantum dots for sentinel lymph node imaging with reduced toxicity. ACS Nano 4, 2531–2538 (2010).
  • Erogbogbo F , YongKT, RoyIet al.: In vivo targeted cancer imaging, sentinel lymph node mapping and multi-channel imaging with biocompatible silicon nanocrystals. ACS Nano5, 413–423 (2011).
  • Chaffer CL , WeinbergRA. A perspective on cancer cell metastasis. Science331, 1559–1564 (2011).
  • Voura EB , JaiswalJK, MattoussiH, SimonSM. Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nat. Med.10, 993–998 (2004).
  • Lidke DS , NagyP, HeintzmannRet al. Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction. Nat. Biotechnol. 22, 198–203 (2004).
  • Gonda K , WatanabeTM, OhuchiN, HiguchiH. In vivo nano-imaging of membrane dynamics in metastatic tumor cells using quantum dots. J. Biol. Chem.285, 2750–2757 (2010).
  • Misra RD . Quantum dots for tumor-targeted drug delivery and cell imaging. Nanomedicine3, 271–274 (2008).
  • Tada H , HiguchiH, WanatabeTM, OhuchiN. In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice. Cancer Res.67, 1138–1144 (2007).
  • Nurunnabi M , ChoKJ, ChoiJS, HuhKM, LeeYK. Targeted near-IR QDs-loaded micelles for cancer therapy and imaging. Biomaterials31, 5436–5444 (2010).
  • Bagalkot V , ZhangL, Levy-NissenbaumEet al. Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Lett. 7, 3065–3070 (2007).
  • Weng KC , NobleCO, Papahadjopoulos-SternbergBet al. Targeted tumor cell internalization and imaging of multifunctional quantum dot-conjugated immunoliposomes in vitro and in vivo. Nano Lett. 8, 2851–2857 (2008).
  • Pan J , LiuY, FengSS. Multifunctional nanoparticles of biodegradable copolymer blend for cancer diagnosis and treatment. Nanomedicine5, 347–360 (2010).
  • Lu RM , ChangYL, ChenMS, WuHC. Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery. Biomaterials32, 3265–3274 (2011).
  • Ashley CE , CarnesEC, PhillipsGKet al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat. Mater. 10, 389–397 (2011).
  • Muhammad F , GuoM, QiWet al. pH-triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids. J. Am. Chem. Soc. 133, 8778–8781 (2011).
  • Petrocca F , LiebermanJ. Promise and challenge of RNA interference-based therapy for cancer. J. Clin. Oncol.29, 747–754 (2011).
  • Agrawal P , StrijkersGJ, NicolayK. Chitosan-based systems for molecular imaging. Adv. Drug Deliv. Rev.62, 42–58 (2010).
  • Tan WB , JiangS, ZhangY. Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference. Biomaterials28, 1565–1571 (2007).
  • Chen HH , HoYP, JiangX, MaoHQ, WangTH, LeongKW. Quantitative comparison of intracellular unpacking kinetics of polyplexes by a model constructed from quantum dot-FRET. Mol. Ther.16, 324–332 (2008).
  • Yezhelyev MV , QiL, O‘ReganRM, NieS, GaoX. Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging. J. Am. Chem. Soc.130, 9006–9012 (2008).
  • Juzenas P , ChenW, SunYPet al. Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv. Drug Deliv. Rev. 60, 1600–1614 (2008).
  • Yaghini E , SeifalianAM, MacRobertAJ. Quantum dots and their potential biomedical applications in photosensitization for photodynamic therapy. Nanomedicine4, 353–363 (2009).
  • Biju V , MundayoorS, OmkumarRV, AnasA, IshikawaM. Bioconjugated quantum dots for cancer research: present status, prospects and remaining issues. Biotechnol. Adv.28, 199–213 (2010).
  • Triesscheijin M , BaasP, SchellensJH, StewartFA. Photodynamic therapy in oncology. Oncologist11, 1034–1044 (2006).
  • Ross JS , SlodkowskaEA, SymmansWF, PusztaiL, RavdinPM, HortobagyiGN. The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine. Oncologist14, 320–368 (2009).
  • Wu X , LiuH, LiuJet al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat. Biotechnol. 21, 41–46 (2003).
  • Yezhelyev MV , Al-HajjA, MorrisCet al.: In situ molecular profiling of breast cancer biomarkers with multicolor quantum dots. Adv. Mater.19, 3146–3151 (2007).
  • Chen C , PengJ, XiaHSet al. Quantum dots-based immunofluorescence technology for the quantitative determination of HER2 expression in breast cancer. Biomaterials 30, 2912–2918 (2009).
  • Chen C , PengJ, XiaHSet al. Quantum-dot-based immunofluorescent imaging of HER2 and ER provides new insights into breast cancer heterogeneity. Nanotechnology 21, 95101 (2010).
  • Chen C , XiaHS, GongYPet al. The quantitative detection of total HER2 load by quantum dots and the identification of a new subtype of breast cancer with different 5-year prognosis. Biomaterials 31, 8818–8825 (2010).
  • Chen C , SunSR, GongYPet al. Quantum dots-based molecular classification of breast cancer by quantitative spectroanalysis of hormone receptors and HER2. Biomaterials 32, 7592–7599 (2011).
  • Li R , DaiH, WheelerTMet al. Prognostic value of Akt-1 in human prostate cancer: a computerized quantitative assessment with quantum dot technology. Clin. Cancer Res. 15, 3568–3573 (2009).
  • Ghazani AA , LeeJA, KlostranecJet al. High throughput quantification of protein expression of cancer antigens in tissue microarray using quantum dot nanocrystals. Nano Lett. 6, 2881–2886 (2006).
  • Xing Y , ChaudryQ, ShenCet al. Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry. Nat. Protoc. 2, 1152–1165 (2007).
  • Sweeney E , WardTH, GrayNet al. Quantitative multiplexed quantum dot immunohistochemistry. Biochem. Biophys. Res. Commun. 374, 181–186 (2008).
  • Huang D , PengX, SuLet al. Comparison and optimization of multiplexed quantum dot-based immunohistofluorescence. Nano Res. 3, 61–68 (2010).
  • Snyder EL , BaileyD, ShipitsinM, PolyakK, LodaM. Identification of CD44v6+/CD24- breast carcinoma cells in primary human tumors by quantum dot-conjugated antibodies. Lab Invest.89, 857–866 (2009).
  • Liu J , LauSK, VarmaVA, KairdolfBA, NieS. Multiplexed detection and characterization of rare tumor cells in Hodgkin‘s lymphoma with multicolor quantum dots. Anal. Chem.82, 6237–6243 (2010).
  • Frasco MF , ChaniotakisN. Bioconjugated quantum dots as fluorescent probes for bioanalytical applications. Anal. Bioanal. Chem.396, 229–240 (2010).
  • Gill R , ZayatsM, WillnerI. Semiconductor quantum dots for bioanalysis. Angew. Chem. Int. Ed. Engl.47, 7602–7625 (2008).
  • Sun B , XieW, YiG, ChenD, ZhouY, ChengJ. Microminiaturized immunoassays using quantum dots as fluorescent label by laser confocal scanning fluorescence detection. J. Immunol. Methods249, 85–89 (2001).
  • Agrawal A , SatheT, NieS. Single-bead immunoassays using magnetic microparticles and spectral-shifting quantum dots. J. Agric. Food Chem.55, 3778–3782 (2007).
  • Zajac A , SongD, QianW, ZhukovT. Protein microarrays and quantum dot probes for early cancer detection. Colloids Surf. B Biointerfaces58, 309–314 (2007).
  • Kerman K , EndoT, TsukamotoM, ChikaeM, TakamuraY, TamiyaE. Quantum dot-based immunosensor for the detection of prostate-specific antigen using fluorescence microscopy. Talanta71, 1494–1499 (2007).
  • Wang J , LiuG, WuH, LinY. Quantum-dot-based electrochemical immunoassay for high-throughput screening of the prostate-specific antigen. Small4, 82–86 (2008).
  • Cui D , PanB, ZhangHet al. Self-assembly of quantum dots and carbon nanotubes for ultrasensitive DNA and antigen detection. Anal. Chem. 80, 7996–8001 (2008).
  • Gokarna A , JinLH, HwangJSet al. Quantum dot-based protein micro- and nanoarrays for detection of prostate cancer biomarkers. Proteomics 8, 1809–1818 (2008).
  • Kim YP , OhYH, OhE, KoS, HanMK, KimHS. Energy transfer-based multiplexed assay of proteases by using gold nanoparticle and quantum dot conjugates on a surface. Anal. Chem.80, 4634–4641 (2008).
  • Xia Z , XingY, SoMK, KohAL, SinclairR, RaoJ. Multiplex detection of protease activity with quantum dot nanosensors prepared by intein-mediated specific bioconjugation. Anal. Chem.80, 8649–8655 (2008).
  • Zhang B , LiangX, HaoLet al. Quantum dots/particle-based immunofluorescence assay: synthesis, characterization and application. J. Photochem. Photobiol. B 94, 45–50 (2009).
  • Soman C , GiorgioT. Sensitive and multiplexed detection of proteomic antigens via quantum dot aggregation. Nanomedicine5, 402–409 (2009).
  • Cheng AK , SuH, WangYA, YuHZ. Aptamer-based detection of epithelial tumor marker mucin 1 with quantum dot-based fluorescence readout. Anal. Chem.81, 6130–6139 (2009).
  • Boeneman K , MeiBC, DennisAMet al. Sensing caspase-3 activity with quantum dot-fluorescent protein assemblies. J. Am. Chem. Soc. 131, 3828–3829 (2009).
  • Jokerst JV , RaamanathanA, ChristodoulidesNet al. Nano-bio-chips for high performance multiplexed protein detection: determinations of cancer biomarkers in serum and saliva using quantum dot bioconjugate labels. Biosens. Bioelectron. 24, 3622–3629 (2009).
  • Hu M , YanJ, HeYet al. Ultrasensitive, multiplexed detection of cancer biomarkers directly in serum by using a quantum dot-based microfluidic protein chip. ACS Nano 4, 488–494 (2010).
  • Cheng W , YanF, DingL, JuH, YinY. Cascade signal amplification strategy for subattomolar protein detection by rolling circle amplification and quantum dots tagging. Anal. Chem.82, 3337–3342 (2010).
  • Gu B , XuC, YangC, LiuS, WangM. ZnO quantum dot labeled immunosensor for carbohydrate antigen 19–19. Biosens. Bioelectron.26, 2720–2723 (2011).
  • Nelson NJ . Circulating tumor cells: will they be clinically useful? J. Natl Cancer Inst.102, 146–148 (2010).
  • Wang DS , HeJB, RosenzweigN, RosenzweigZ. Superparamagnetic Fe2O3 Beads-CdSe/ZnS quantum dots core-shell nanocomposite particles for cell separation. Nano Lett.4, 409–413 (2004).
  • Selvan ST , PatraPK, AngCY, YingJY. Synthesis of silica-coated semiconductor and magnetic quantum dots and their use in the imaging of live cells. Angew. Chem. Int. Ed. Engl.46, 2448–2452 (2007).
  • Di Corato R , BigallNC, RagusaAet al. Multifunctional nanobeads based on quantum dots and magnetic nanoparticles: synthesis and cancer cell targeting and sorting. ACS Nano 5, 1109–1121 (2011).
  • Hsieh YH , LaiLJ, LiuSJ, LiangKS. Rapid and sensitive detection of cancer cells by coupling with quantum dots and immunomagnetic separation at low concentrations. Biosens. Bioelectron.26, 4249–4252 (2011).
  • Xie HY , ZuoC, LiuYet al. Cell-targeting multifunctional nanospheres with both fluorescence and magnetism. Small 1, 506–509 (2005).
  • Xie HY , XieM, ZhangZLet al. Wheat germ agglutinin-modified trifunctional nanospheres for cell recognition. Bioconjug. Chem. 18, 1749–1755 (2007).
  • Song EQ , WangGP, XieHYet al. Visual recognition and efficient isolation of apoptotic cells with fluorescent-magnetic-biotargeting multifunctional nanospheres. Clin. Chem. 53, 2177–2185 (2007).
  • Song EQ , HuJ, WenCYet al. Fluorescent-magnetic-biotargeting multifunctional nanobioprobes for detecting and isolating multiple types of tumor cells. ACS Nano 5, 761–770 (2011).
  • Stroh M , ZimmerJP, DudaDGet al. Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo. Nat. Med. 11, 678–682 (2005).
  • Estrada CR , SalangaM, BielenbergDRet al. Behavioral profiling of human transitional cell carcinoma ex vivo. Cancer Res. 66, 3078–3086 (2006).
  • Chung GG , ZerkowskiMP, GhoshS, CampRL, RimmDL. Quantitative analysis of estrogen receptor heterogeneity in breast cancer. Lab Invest.87, 662–669 (2007).
  • Liu J , LauSK, VarmaVAet al. Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots. ACS Nano 4, 2755–2765 (2010).
  • Joyce JA , PollardJW. Microenvironmental regulation of metastasis. Nat. Rev. Cancer9, 239–252 (2009).
  • Peng CW , LiuXL, LiuX, LiY. Co-evolution of cancer microenvironment reveals distinctive patterns of gastric cancer invasion: laboratory evidence and clinical significance. J. Transl. Med.8, 101 (2010).
  • Peng CW , LiuXL, ChenCet al. Patterns of cancer invasion revealed by QDs-based quantitative multiplexed imaging of tumor microenvironment. Biomaterials 32, 2907–2917 (2011).
  • Liu XL , PengCW, ChenCet al. Quantum dots-based double-color imaging of HER2 positive breast cancer invasion. Biochem. Biophys. Res. Commun. 409, 577–582 (2011).
  • Dubertret B , SkouridesP, NorrisDJ, NoireauxV, BrivanlouAH, LibchaberA. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science298, 1759–1762 (2002).
  • Jaiswal J K, Mattoussi H, Mauro JM, Simon SM. Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat. Biotechnol.21, 47–51 (2003).
  • Hardman R . A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ. Health Perspect.114, 165–172 (2006).
  • Choi AO , BrownSE, SzyfM, MaysingerD. Quantum dot-induced epigenetic and genotoxic changes in human breast cancer cells. J. Mol. Med.86, 291–302 (2008).
  • Fitzpatrick JA , AndrekoSK, ErnstLA, WaggonerAS, BallouB, BruchezMP. Long-term persistence and spectral blue shifting of quantum dots in vivo. Nano Lett.9, 2736–2741 (2009).
  • Zhang LW , Monteiro-RiviereNA. Mechanisms of quantum dot nanoparticle cellular uptake. Toxicol. Sci.110, 138–155 (2009).
  • Yong KT , RoyI, DingH, BergeyEJ, PrasadPN. Biocompatible near-infrared quantum dots as ultrasensitive probes for long-term in vivo imaging applications. Small5, 1997–2004 (2009).
  • Chu M , WuQ, YangHet al. Transfer of quantum dots from pregnant mice to pups across the placental barrier. Small 6, 670–678 (2010).
  • Pelley JL , DaarAS, SanerMA. State of academic knowledge on toxicity and biological fate of quantum dots. Toxicol. Sci.112, 276–296 (2009).
  • Su Y , PengF, JiangZet al.: In vivo distribution, pharmacokinetics, and toxicity of aqueous synthesized cadmium-containing quantum dots. Biomaterials32, 5855–5862 (2011).
  • Yang RS , ChangLW, WuJPet al. Persistent tissue kinetics and redistribution of nanoparticles, quantum dot 705, in mice: ICP-MS quantitative assessment. Environ. Health Perspect. 115, 1339–1343 (2007).
  • Choi HS , LiuW, MisraPet al. Renal clearance of quantum dots. Nat. Biotechnol. 25, 1165–1170 (2007).
  • Choi HS , LiuW, LiuFet al. Design considerations for tumour-targeted nanoparticles. Nat. Nanotechnol. 5, 42–47 (2010).
  • Choi HS , IpeBI, MisraP, LeeJH, BawendiMG, FrangioniJV. Tissue- and organ-selective biodistribution of NIR fluorescent quantum dots. Nano Lett.9, 2354–2359 (2009).
  • Su Y , HuM, FanCet al. The cytotoxicity of CdTe quantum dots and the relative contributions from released cadmium ions and nanoparticle properties. Biomaterials 31, 4829–4834 (2010).
  • Barua S , RegeK. Cancer-cell-phenotype-dependent differential intracellular trafficking of unconjugated quantum dots. Small5, 370–376 (2009).
  • Williams Y , SukhanovaA, NowostawskaMet al. Probing cell-type-specific intracellular nanoscale barriers using size-tuned quantum dots. Small 5, 2581–2588 (2009).
  • Geys J , NemmarA, VerbekenEet al. Acute toxicity and prothrombotic effects of quantum dots: impact of surface charge. Environ. Health Perspect. 116, 1607–1613 (2008).
  • Clift MJ , BrandenbergerC, Rothen-RutishauserB, BrownDM, StoneV. The uptake and intracellular fate of a series of different surface coated quantum dots in vitro. Toxicology286, 58–68 (2011).
  • Hauck TS , AndersonRE, FischerHC, NewbiggingS, ChanWC. In vivo quantum-dot toxicity assessment. Small6, 138–144 (2010).
  • Selvan ST , PatraPK, AngCY, YingJY. Synthesis of silica-coated semiconductor and magnetic quantum dots and their use in the imaging of live cells. Angew. Chem. Int. Ed. Engl.46, 2448–2452 (2007).
  • Erogbogbo F , YongKT, RoyI, XuG, PrasadPN, SwihartMT. Biocompatible luminescent silicon quantum dots for imaging of cancer cells. ACS Nano2, 873–878 (2008).
  • Hu X , GaoX. Silica-polymer dual layer-encapsulated quantum dots with remarkable stability. ACS Nano4, 6080–6086 (2010).
  • Erogbogbo F , TienCA, ChangCWet al. Bioconjugation of luminescent silicon quantum dots for selective uptake by cancer cells. Bioconjug. Chem. 22, 1081–1088 (2011).
  • Bottrill M , GreenM. Some aspects of quantum dot toxicity. Chem. Commun.47, 7039–7050 (2011).
  • Xu H , ChenC, PengJet al. Evaluation of bioconjugate efficiency of different quantum dots probes immunostaining tumor marker protein. Appl. Spectrosc. 64, 847–852 (2010).
  • Yang XQ , ChenC, PengCWet al. Quantum dot-based quantitative immunofluorescence detection and spectrum analysis of epidermal factor receptor in breast cancer tissue arrays. Int. J. Nanomed. 6, 2265–2273 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.